If you liked this article you might like

PlasmaTech Biopharma (PTBI) Stock Up After Licensing Juvenile Batten Disease Treatment
Rare Disease Drug Demand, Soros Interest Raising PlasmaTech Profile
PlasmaTech Biopharmaceuticals (PTBI) Stock Rises on 'Buy' Rating Coverage Initiation